Skip to content

Clinical trials

Medulloblastoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Medulloblastoma Country / region: France Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20071
20111
20121
20132
20142
20161
20171
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status4
Terminated3
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gustave Roussy, Cancer Campus, Grand Paris3
Novartis Pharmaceuticals2
Bristol-Myers Squibb1
Celgene1
Central Hospital, Nancy, France1
Centre Leon Berard1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
Institut Curie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Medulloblastoma18
Glioma7
Brain Neoplasms6
Neuroblastoma6
Ependymoma5
Recurrence5
Rhabdomyosarcoma4
Sarcoma, Ewing4
Central Nervous System Neoplasms3
Neuroectodermal Tumors, Primitive3

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.